Thomas W Meeks
Biographic Data
| ID | 7972888 |
|---|---|
| NAME | Thomas W Meeks |
| GIVEN NAMES | Thomas W |
| FAMILY NAME | Meeks |
| SIGNATURE | MEEKS T W |
| AFFILIATIONS | Oregon Health & Science University |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2007 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Reconsidering the usefulness of long-term high-dose buprenorphine
Buprenorphine has been successfully used for decades in the treatment of opioid use disorder, yet there are complexities to its use that warrant attention to maximize its utility. While the package insert of the combination product buprenorphine\naloxone continues to recommend a maximum dose of 16 mg daily for maintenance, the emergence of fentanyl and synthetic analogs in the current drug supply may be limiting the effectiveness of this standard…
A New Brief Instrument for Assessing Decisional Capacity for Clinical Research
CONTEXT: There is a critical need for practical measures for screening and documenting decisional capacity in people participating in different types of clinical research. However, there are few reliable and validated brief tools that could be used routinely to evaluate individuals' capacity to consent to a research protocol. OBJECTIVE: To describe the development, testing, and proposed use of a new practical instrument to assess decision-making …
No prominent works on this page.
A New Brief Instrument for Assessing Decisional Capacity for Clinical Research
CONTEXT: There is a critical need for practical measures for screening and documenting decisional capacity in people participating in different types of clinical research. However, there are few reliable and validated brief tools that could be used routinely to evaluate individuals' capacity to consent to a research protocol. OBJECTIVE: To describe the development, testing, and proposed use of a new practical instrument to assess decision-making …
Reconsidering the usefulness of long-term high-dose buprenorphine
Buprenorphine has been successfully used for decades in the treatment of opioid use disorder, yet there are complexities to its use that warrant attention to maximize its utility. While the package insert of the combination product buprenorphine\naloxone continues to recommend a maximum dose of 16 mg daily for maintenance, the emergence of fentanyl and synthetic analogs in the current drug supply may be limiting the effectiveness of this standard…
Medicine (2 works) · Alternative medicine (1 works) · Anesthesia (1 works) · Applied Psychology (1 works) · Buprenorphine (1 works) · Clinical Psychology (1 works) · Clinical trial (1 works) · Concurrent validity (1 works) · Construct validity (1 works) · Criterion validity (1 works)